Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cardiovascular and Interventional Radiology

• Publication date

  2015-03-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00270-015-1080-9PMID 25799948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases

  2014cited by this paper
• Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

  2014cited by this paper
• Radioembolization for Treatment of Salvage Patients with Colorectal Cancer Liver Metastases: A Systematic Review

  2013cited by this paper
• Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.

  2013cited by this paper
• Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

  2013cited by this paper
• Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study

  2013cited by this paper
• Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.

  2012cited by this paper
• First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)

  2012cited by this paper
• Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial

  2012cited by this paper
• Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer

  2011cited by this paper
• Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

  2011cited by this paper
• Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

  2010cited by this paper
• Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.

  2009cited by this paper
• Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients

  2008cited by this paper
• Actual 10-year survival after resection of colorectal liver metastases defines cure.

  2007cited by this paper
• Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.

  2007cited by this paper
• Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement

  2006cited by this paper
• Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.

  2006cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases

  2002cited by this paper
• Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?

  2002cited by this paper
• Chemoembolization of hepatic malignancies.

  1994cited by this paper
• Factors influencing the natural history of colorectal liver metastases.

  1994cited by this paper
• Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases

  1991cited by this paper
• The blood supply of neoplasms in the liver.

  1954cited by this paper

• A machine learning-based prognostic stratification of locoregional interventional therapies for patients with colorectal cancer liver metastases: a real-world study

  2025cites this paper
• Prognostic value of sarcopenia in patients with unresectable colorectal liver metastases after drug-eluting beads transcatheter arterial chemoembolization: a single center retrospective study

  2025cites this paper
• Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study.

  2025cites this paper
• Combination of Irreversible Electroporation and Clostridium novyi-NT Bacterial Therapy for Colorectal Liver Metastasis

  2025cites this paper
• Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy

  2025cites this paper
• Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?

  2024cites this paper
• Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases

  2024cites this paper
• Drug-eluting beads loaded with irinotecan to treat synchronous liver-only metastases of colorectal cancer non-responsive to bevacizumab-based chemotherapy.

  2023cites this paper
• Transarterial Chemoembolization with Irinotecan-loaded Beads Followed by Arterial Infusion of 5-Fluorouracil for Metastatic Liver Tumors Refractory to Standard Systemic Chemotherapy

  2023cites this paper
• Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients with unresectable colorectal liver metastases compared with mono-CT-HDRBT

  2023cites this paper
• Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases

  2022cites this paper
• Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis

  2022cites this paper
• Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients

  2022cites this paper
• Intra-arterial therapy for unresectable colorectal liver metastases: A meta-analysis.

  2021cites this paper
• Chronic Hepatitis B

  2021cites this paper
• CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer

  2021cites this paper
• Tailored Systemic Therapy for Colorectal Cancer Liver Metastases

  2021cites this paper
• CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation

  2021cites this paper
• Review of Intra-Arterial Therapies for Colorectal Cancer Liver Metastasis

  2021cites this paper
• Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis

  2020influential citation
• Feasibility and Safety of CT-Guided High-Dose-Rate Brachytherapy Combined with Transarterial Chemoembolization Using Irinotecan-Loaded Microspheres for the Treatment of Large, Unresectable Colorectal Liver Metastases.

  2020cites this paper
• Updates of colorectal cancer liver metastases therapy: review on DEBIRI

  2020cites this paper
• Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: What every interventional radiologist should know

  2020cites this paper
• TACE in colorectal liver metastases – different outcomes in right-sided and left-sided primary tumour location

  2020cites this paper
• The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

  2020cites this paper
• Transarterial Chemoembolisation and Combined Therapy

  2020cites this paper
• Interventional Radiology in Management of Colorectal Carcinoma Metastasis

  2020cites this paper
• Onkologische Embolisation

  2020cites this paper
• Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases

  2019cites this paper
• Chemoembolization for Colorectal Liver Metastases

  2019cites this paper
• Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options

  2019cites this paper
• DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

  2019cites this paper
• Development of Repeatable Microcatheter Access Port for Intra-arterial Therapy of Liver Cancer

  2018cites this paper
• Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.

  2018cites this paper
• Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.

  2018cites this paper
• Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study

  2018cites this paper
• Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis.

  2018cites this paper
• The role of interventional oncology in the treatment of colorectal cancer liver metastases

  2018cites this paper
• Hipertermia magnética antitumoral medida por nanopartículas magnéticas RGD en el tratamiento de metástasis hepáticas en un modelo experimental murino

  2018cites this paper
• Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization

  2017cites this paper
• Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

  2017cites this paper
• Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

  2017cites this paper
• Liver metastases: Basic principles of treatment and clinical data

  2017cites this paper
• Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.

  2017cites this paper
• The state of regional therapy in the management of metastatic colorectal cancer to the liver

  2016cites this paper
• Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.

  2016cites this paper
• Traitement des métastases hépatiques d’origine colorectale réfractaires à la chimiothérapie systémique, par injection intra-artérielle hépatique de billes chargées à l’Irinotécan (DEBIRI®)

  2016cites this paper
• Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors.

  2016cites this paper
• In vitro study of physical properties of various embolization particles regarding morphology before, during and after catheter passage

  2016cites this paper
• Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.

  2016cites this paper